1 of 102

Absorption of Drug

2 of 102

Contents

  • Absorption mechanism,
  • Oral drug absorption,
  • Factors affecting:
    • Physicochemical,
    • dosage form related,
    • patient related.
  • Drug absorption through other routes:
    • transdermal,
    • nasal,
    • buccal,
    • Ocular
    • sublingual.
  • In-vitro, In-situ and In-vivo models for drug absorption studies.

Absorption of Drug

2

2/5/2025

3 of 102

Introduction

  • Drug absorption

Absorption of Drug

3

2/5/2025

4 of 102

Introduction

  • Drug absorption
  • Routes of administration
    • Oral
    • Parenteral
    • Topical

Absorption of Drug

4

2/5/2025

5 of 102

Mechanisms of drug transport

  • Intercellular (transcellular) transport
    • Passive transport
      • Passive diffusion
      • Pore transport
      • Ion-pair transport
      • Facilitated diffusion
    • Active transport
      • Primary
      • Secondary
        • Symport
        • Antiport

Absorption of Drug

5

2/5/2025

6 of 102

Mechanisms of drug transport

  • Intracellular (paracellular) transport
    • Tight junctions of epithelial cells
    • Persorption
  • Endocytosis
    • Pinocytosis
    • Phagocytosis

Absorption of Drug

6

2/5/2025

7 of 102

Passive diffusion

  • Passive transport is a type of membrane transport that does not require energy to move substances across cell membranes.
  • Energy independent process
  • Expressed by Fick’s first law of diffusion
    • The drug molecules moves from a region of higher concentration to one of lower concentration until equilibrium is attained and the rate of diffusion is directly proportional to the concentration gradient across membrane.

Absorption of Drug

7

2/5/2025

8 of 102

Passive diffusion

  • Characteristics of passive diffusion
    • Downhill transport
    • Process- energy independent & non saturable
    • Drug transfer directly proportional to conc gradient
    • Greater the area & lesser thickness of membrane, faster diffusion
    • Process is rapid over short distance and slower over long distance

Absorption of Drug

8

2/5/2025

9 of 102

Passive diffusion

Characteristics of passive diffusion

    • Equilibrium is attained when the concentration on either side of membrane becomes equal.
    • Rate of transfer of unionised drug is more than ionised.
    • Greater partition coefficient of drug, faster the absorption.
    • Drug diffusion is rapid- volume of GI fluid is low.
    • Process id dependent on molecular size of the drug.

Absorption of Drug

9

2/5/2025

10 of 102

Passive diffusion

  • Equation follows first order kinetics hence passive diffusion process is first order process.

Absorption of Drug

10

2/5/2025

11 of 102

Pore transport

  • Pore transport is a process that moves small molecules through cell membranes via pores or channels
  • Connective transport/ filtration
  • Transport of molecules into the cell through the protein channels present in the cell membrane.
  • Characteristics
    • Driving force- hydrostatic pressure/ osmotic difference across the cell membrane.
    • Water flux promotes transport-
    • Absorption- low molecular size
    • Water soluble drugs- urea, water, sugars
    • Chain like or linear compounds absorbed by filtration.

Absorption of Drug

11

2/5/2025

12 of 102

Ion pair transport

  • Is a process that increases the rate at which polar drugs can cross lipid membranes.
  • It also improves the bioavailability of hydrophilic ionizable drugs. 
  • Complex- liphophilic and water soluble
  • Absorbed by passive diffusion.
  • Example- Propranolol- oleic acid, quaternary ammonium compounds.

Absorption of Drug

12

2/5/2025

13 of 102

Carrier-Mediated transport

  • Carrier-mediated transport is a process that moves molecules across cell membranes using carrier proteins. It's a combination of diffusion and a chemical reaction. 
  •  carrier protein binds to a molecule or ion
  • The carrier protein changes shape
  • The molecule or ion is released on the other side of the membrane

Absorption of Drug

13

2/5/2025

14 of 102

Carrier-Mediated transport

  • Faster than passive diffusion
  • Carriers- component of membrane
  • Reversible/ covalent bonding
  • Carrier-solute complex-
    • transverse across membrane
    • dissociation of solute
    • carrier –returns to original site
  • Carriers – proteins/ enzymes

Absorption of Drug

14

2/5/2025

A- Passive diffusion

B- Carrier mediated transport

15 of 102

Carrier-Mediated transport

  • Characteristics
    • Carrier protein has uncharged outer surface.
    • Carrier protein soluble in lipid.
    • Carrier- any direction - work efficiently.
    • Transport process is structure specific.
    • System is structure specific.
    • Limited carrier- competition – similar agents.
    • System is capacity limited.

Absorption of Drug

15

2/5/2025

16 of 102

Carrier-Mediated transport

  • Characteristics
    • Mixed order kinetics
    • Bioavailability decreases with increasing dose
    • Example – Vit B1, B2, B12
    • Absorption window
  • Two types
    • Facilitated diffusion
    • Active transport

Absorption of Drug

16

2/5/2025

17 of 102

Carrier-Mediated transport

Absorption of Drug

17

2/5/2025

Intestine Transporters and Examples of Drugs Transported

Transporter

Examples

Amino acid transporter 

Gabapentin

D-Cycloserine

Methyldopa

Baclofen

L-dopa

 

Oligopeptide transporter

 

Cefadroxil

Cephradine

Cefixime

Ceftibuten

Cephalexin

Captopril

Lisinopril

Thrombin inhibitor

Phosphate transporter

Fostomycin

Foscarnet

Bile acid transporter

S3744

 

Glucose transporter

p-Nitrophenyl beta

D-glucopyranoside 

 

P-glycoprotein efflux

Etoposide

Vinblastine

 

Cyclosporin A

 

Monocarboxylic acid

transporter

Salicylic acid

Benzoic acid

Pravastatin

 

18 of 102

Facilitated diffusion

  • Characteristics
    • Downhill transport
    • Faster than passive diffusion
    • Driving force- concentration gradient
    • Passive process
    • Energy independent
    • Vitamin B1, B2 & B12
    • Intrinsic factor-B12

Absorption of Drug

18

2/5/2025

19 of 102

Active transport diffusion

  • Two Types
    • Primary active transport
    • Secondary active transport

  • Primary active transport
    • Direct ATP requirement
    • Process transfers only ion/ molecule in one direction
    • Hence called uniporter
    • Absorption of glucose
    • Two types
      • Ion transporters
      • ABC transporters

Absorption of Drug

19

2/5/2025

20 of 102

Active transport diffusion

  • Primary active transport
    • Ion transporters
      • ATP driven ion pump- proton pump
      • Two types
        • Organic anion transporter
          • atrovastatin
        • Organic cationic transporter
          • diphenhydramine

Absorption of Drug

20

2/5/2025

21 of 102

Active transport diffusion

  • Primary active transport
    • ABC (ATP binding cassette) transporters
      • Transport small molecules (drug and toxins) out of cell.
      • Exsorption
      • Efflux pumps
      • ABC transporter example- p-glycoprotein (P-gp)
      • P-gp called multidrug resistant protein
      • Drug- anticancer drugs

Absorption of Drug

21

2/5/2025

22 of 102

Active transport diffusion

  • Secondary active transport
    • No direct requirement of ATP
    • Concentration gradient
    • Two types
      • Symport (co transport)
      • Antiport (counter transport)

Absorption of Drug

22

2/5/2025

23 of 102

Active transport diffusion

  • Secondary active transport
    • Symport
      • Both molecules moves in same direction
      • Na+ - glucose symporter : uses potential energy of sodium concentration gradient to move glucose against concentration gradient.
      • H+ - coupled peptide transporter – absorption of peptide like drugs- beta lactam antibiotics.
    • Antiport
      • Molecules moves in opposite direction

Absorption of Drug

23

2/5/2025

24 of 102

Active transport diffusion

  • Characteristics
    • Uphill transport
    • Faster than passive diffusion
    • Energy required
    • Inhibited by metabolic poison
    • Fluorides, cyanide,
    • Endogenous material absorbed.
    • Drugs- 5 flurouracil, 5-flurobromacil via pyrimidine transport.
    • Methyl dopa, levodopa via L-amino acid transport system.
    • Enalapril via peptide carrier system.

Absorption of Drug

24

2/5/2025

25 of 102

Active transport diffusion

Absorption of Drug

25

2/5/2025

26 of 102

Endocytosis

  • Engulfing extracellular material.
  • Fats, starch, insulin, vitamin A, D, E, K.
  • Drug absorbed in lymphatic system- bypass first pass.
  • Two types
    • Phagocytosis (cell eating)
    • Pinocytosis (cell drinking)

Absorption of Drug

26

2/5/2025

27 of 102

Factors affecting drug absorption

  • Pharmaceutical factors
    • Physicochemical properties of drug
    • Dosage form related factors
  • Patient related factors

Absorption of Drug

27

2/5/2025

28 of 102

Physicochemical factors

  • Drug solubility & dissolution rate
    • Rate determining steps
      • Dissolution- hydrophobic like griseofulvin, spironolactone
      • Permeation- hydrophilic like neomycin
      • BCS- Amidon et al
        • Class I drug: high solubility/ high permeability
        • Class II drugs: low solubility/ high permeability
        • Class III drugs: high solubility/ low permeability
        • Class IV drugs: low solubility/ low permeability

Absorption of Drug

28

2/5/2025

29 of 102

Physicochemical factors

  • Drug solubility & dissolution rate
    • Intrinsic solubility
      • Maximum amount of solute dissolved in a given solvent under standard conditions of temperature, pressure and pH.
      • Static property
    • Dissolution rate
      • Amount of solid substance that goes into solution per unit time under standard conditions of temperature, pH and solvent composition and constant surface area.
      • Dynamic process

Absorption of Drug

29

2/5/2025

30 of 102

Physicochemical factors

  • Theories of dissolution
    • Dissolution
      • Solid substance solubilises in a given solvent.
      • Mass transfer from the solid surface to the liquid phase.
    • Theories
      • Diffusion layer model
      • Surface renewal theory
      • Limited solvation theory

Absorption of Drug

30

2/5/2025

31 of 102

Physicochemical factors

  • Diffusion layer model
    • Two steps
    • Solution of the solid to form stagnant film or diffusive layer which is saturated with the drug
    • Diffusion of the soluble solute from the stagnant layer to the bulk of the solution; this is RDS in drug dissolution

Absorption of Drug

31

2/5/2025

32 of 102

Physicochemical factors

  • Diffusion layer model

Absorption of Drug

32

2/5/2025

  • Diffusion layer or stagnant film
    • Formation of thin film or layer at solid-liquid interface is diffusion layer
    • Diffusion layer is saturated with drug
    • Rapid step
  • Diffusion of soluble solute
    • From stagnant layer to bulk of the solution
    • Slower step, hence rate determining

33 of 102

Physicochemical factors

  • Diffusion layer model

Absorption of Drug

33

2/5/2025

  • In dissolution theory, it is assumed that an
    • Solute molecules exists in the concentrations from Cs to Cb. beyond the static layer at x greater than h,
    • mixing occurs in the solution and the drug is found in uniform concentration, Cb throughout the bulk phase.
    • At x= 0 drug in the solid is in equilibrium with drug in diffusion layer.
    • The gradient in the concentration with the distance is constant as shown in fig.
    • This is the gradient represented by the term, (Cs-C)/h.
      • When Cb is considerably lower than Cs, the system is represented by Sink conditions

34 of 102

Physicochemical factors

  • Diffusion layer model
    • The rate of dissolution is given by Noyes & Whitney

Where,

dc/dt= dissolution rate of the drug

K= dissolution rate constant

Cs= concentration of drug in stagnant layer

Cb= concentration of drug in the bulk of the solution at time t

Absorption of Drug

34

2/5/2025

35 of 102

Physicochemical factors

  • Diffusion layer model
    • Modified Noyes-Whitney’s Equation

Where,

D= diffusion coefficient of drug.

A= surface area of dissolving solid.

Kw/o= water/oil partition coefficient of drug.

V= volume of dissolution medium.

h= thickness of stagnant layer.

(Cs – Cb )= conc. gradient for diffusion of drug.

Absorption of Drug

35

2/5/2025

36 of 102

Physicochemical factors

  • Diffusion layer model
    • Sink conditions

    • In the derivation of equation it is assumed that
      • D and h remains constant
      • the static diffusion layer thickness is altered by the force of agitation at the surface of the dissolving tablet.
      • Surface area A never remains constant as powder, granule or tablet dissolves and it is difficult to obtain an accurate measure of A.

Absorption of Drug

36

2/5/2025

37 of 102

Physicochemical factors

  • Diffusion layer model
    • Sink conditions
      • This is first order dissolution rate process, for which the driving force is concentration gradient.
      • This is true for in-vitro dissolution which is characterized by non-sink conditions.
      • The in-vivo dissolution is rapid as sink conditions are maintained by absorption of drug in systemic circulation i.e. Cb=0 and rate of dissolution is maximum.
      • Under sink conditions, if the volume and surface area of the solid are kept constant, then

Absorption of Drug

37

2/5/2025

38 of 102

Physicochemical factors

  • Diffusion layer model
    • Sink conditions
      • Under sink conditions, if the volume and surface area of the solid are kept constant, then

      • This represents that the dissolution rate is constant under sink conditions and follows zero order kinetics.

Absorption of Drug

38

2/5/2025

39 of 102

Physicochemical factors

  • Diffusion layer model
    • Dissolution under sink & non sink conditions

Absorption of Drug

39

2/5/2025

Conc. of dissolved drug

Time

first order dissolution under non-sink condition

zero order dissolution under sink condition

40 of 102

Physicochemical factors

  • Diffusion layer model
    • Sink conditions can be achieved by
      • Bathing solid in fresh solvent from time to time
      • Increasing volume of dissolution fluid
      • Removing dissolved drug by partitioning
      • Adding water miscible solvent
      • Adding adsorbents

Absorption of Drug

40

2/5/2025

41 of 102

Physicochemical factors

  • Diffusion layer model
    • Hixon & Crowell’s cubic root law
    • takes into account the particle size decrease and change in surface area,

W01/3 – W1/3 = Kt

Where,

W0=original mass of the drug

W=mass of drug remaining to dissolve at time t

Kt=dissolution rate constant.

Absorption of Drug

41

2/5/2025

42 of 102

Physicochemical factors

  • Danckwert’s Model
    • Turbulence in dissolution medium exists at solid/liquid interface
    • Dankwert takes into account the eddies or packets that are present in the agitated fluid which reach the solid-liquid interface, absorb the solute by diffusion and carry it into the bulk of solution.
    • These packets get continuously replaced by new ones and expose to new solid surface each time, thus the theory is called as surface renewal theory.

Absorption of Drug

42

2/5/2025

43 of 102

Physicochemical factors

  • Danckwert’s Model
    • The Danckwert’s model is expressed by equation

Where,

m = mass of solid dissolved

Gamma (γ) = rate of surface renewal

Absorption of Drug

43

2/5/2025

44 of 102

Physicochemical factors

  • Interfacial Barrier model
    • An intermediate concentration can exist at the interface as a result of solvation mechanism and is function of solubility
    • Interfacial barrier model is expressed by equation

Where,

G = dissolution rate per unit area

Ki = effective interfacial transport constant

Absorption of Drug

44

2/5/2025

45 of 102

Physicochemical factors

  • Factors affecting drug dissolution and dissolution rate
    • Physicochemical properties of drug
    • Dosage form factors

Absorption of Drug

45

2/5/2025

46 of 102

Physicochemical factors

  • Particle size and effective surface area
    • Particle size and surface area are inversely related to each other.
    • Two types of surface area
      • Absolute surface area which is the total surface area of any particle.
      • Effective surface area which is the area of solid surface exposed to the dissolution medium.
    • Effective surface area is directly related to the dissolution rate.
    • Greater the effective surface area, more intimate the contact between the solid surface and the aqueous solvent and faster the dissolution.

Absorption of Drug

46

2/5/2025

47 of 102

Physicochemical factors

  • Polymorphism & amorphism
    • When a substance exists in more than one crystalline form, the different forms are designated as polymorphs and the phenomenon as Polymorphism.
    • Stable polymorphs has lower energy state, higher M.P. and least aqueous solubility.
    • Metastable polymorphs has higher energy state, lower M.P. and higher aqueous solubility.
    • Eg. Chloramphenicol palmitate B

Absorption of Drug

47

2/5/2025

48 of 102

Physicochemical factors

  • Polymorphism & amorphism
    • Amorphous form of drug which has no internal crystal structure represents higher energy state and greater aqueous solubility than crystalline forms.
    • E.g.- amorphous form of novobiocin is 10 times more soluble than the crystalline form.
    • Thus, the order for dissolution of different solid forms of drug is –

amorphous > metastable > stable

Absorption of Drug

48

2/5/2025

49 of 102

Physicochemical factors

  • Hydrates/ Solvates
    • The stoichiometric type of adducts where the solvent molecules are incorporated in the crystal lattice of the solid are called as the solvates.
    • When the solvent in association with the drug is water, the solvate is known as hydrate.
    • The organic solvates have greater aqueous solubility than the nonsolvates.
    • E.g. – chloroform solvates of griseofulvin is more water soluble than their nonsolvated forms

Absorption of Drug

49

2/5/2025

50 of 102

Physicochemical factors

  • Salt form of drug
    • Dissolution rate of weak acids and weak bases can be enhance by converting them into their salt form.
    • With weakly acidic drugs, a strong base salt is prepared like sodium and potassium salts of barbiturates and sulfonamides.
    • With weakly basic drugs, a strong acid salt is prepared like the hydrochloride or sulfate salts of alkaloidal drugs.

Absorption of Drug

50

2/5/2025

51 of 102

Physicochemical factors

  • pH partition hypothesis
    • Theory states that for drug compounds molecular weight greater than 100 dalton, primarily transported across biomembrane by passive diffusion and process of absorption is governed by:
      • pKa of drug
      • Lipid solubility of unionised drug
      • pH at the absorption site
    • Most drugs are- weak electrolytes
    • Ionisation depends on the pH of the biological fluid.
    • Unionised with sufficient lipid soluble drug cross barrier until equilibrium is attained.

Absorption of Drug

51

2/5/2025

52 of 102

Physicochemical factors

  • pH partition hypothesis
    • Theory is based on following assumptions
      • GIT is a simple lipoidal barrier
      • Larger fraction of unionised drug, faster absorption
      • Greater the partition coefficient of unionised drug, better absorption
    • Drug pka and GIT pH
      • Unionised fraction is function of pKa of drug and pH of GIF
      • Low pKa of acidic drug- strong acid- greater ionisation
      • Higher pKa of basic drug- strong base- greater ionisation

Absorption of Drug

52

2/5/2025

53 of 102

Physicochemical factors

  • pH partition hypothesis
    • Drug pka and GIT pH
      • Henderson-Hasselbach equations

Absorption of Drug

53

2/5/2025

54 of 102

Physicochemical factors

  • pH partition hypothesis
    • Drug pKa and GIT pH
      • Shore et al
        • Therapeutic ratio (R) given by

Absorption of Drug

54

2/5/2025

55 of 102

Physicochemical factors

  • pH partition hypothesis
    • Drug pka and GIT pH
      • Generalisations regarding ionisation & absorption of acids
      • Very weak acids (pKa > 8): unionised at all pH values, absorption is rapid and independent of GI pH. Pentobarbital, hexobarbital, phenytoin, ethosuximide
      • Moderately weak acid (Pka, 2.5 – 7.5): absorption is pH dependent, better absorbed from acidic pH (pH<pKa). Cloxacillin, aspirin, ibuprofen, phenylbutazone
      • Strong acid (Pka< 2.5): ionised in the entire pH range of GIT, poorly absorbed. Disodium cromoglycate

Absorption of Drug

55

2/5/2025

56 of 102

Physicochemical factors

  • pH partition hypothesis
    • Drug pka and GIT pH
      • Generalisations regarding ionisation & absorption of Bases
      • Very weak bases (pKa < 5): unionised at all pH values, absorption is rapid and independent of GI pH. Theophylline, caffeine, oxazepam, diazepam, nitrazepam
      • Moderately weak bases (Pka, 5 – 11): absorption is pH dependent, better absorbed from alkaline pH. Morphine, chloroquine, imepramine, amitriptyline
      • Strong bases (Pka > 11): ionised in the entire pH range of GIT, poorly absorbed. Mecamylamine, Guanethidine

Absorption of Drug

56

2/5/2025

57 of 102

Physicochemical factors

  • pH partition hypothesis
    • Aqueous Solubility
      • Total aqueous solubility (St): Sum of concentration of ionised and unionised drug in solution.
      • The solubility of unionised form of drug is known as intrinsic solubility of drug.
      • For acidic drugs

      • For basic drugs

Absorption of Drug

57

2/5/2025

58 of 102

Physicochemical factors

  • pH partition hypothesis
    • Conclusions and generalisations
      • For weakly acidic drugs
        • When pH > pKa, St >> Sa, ionisation of drug increases
        • When pH = pKa, St = 2Sa, 50 % ionisation
        • When pH< pKa, St = Sa, drug exists as unionised form
      • For basic drugs
        • When pH > pKa, St = Sb, drug exists as unionised form
        • When pH = pKa, St = 2Sb, 50 % ionisation
        • When pH< pKa, St >> Sb, ionisation of drug increases

Absorption of Drug

58

2/5/2025

59 of 102

Physicochemical factors

  • pH partition hypothesis

Absorption of Drug

59

2/5/2025

60 of 102

Physicochemical factors

  • Liphophilicity and drug absorption
    • Hydrophilic-lipophilic balance- optimum absorption
    • Partition coefficient
    • Rapid rate of absorption (Ko/w, 0.12-100): Thiopental (67%), Phenylbutazone (54%), Benzoic acid (54%), salicylic acid (60%).
    • Moderate rate of absorption (Ko/w, 0.002 – 0.03): Aspirin (21%), Theophylline (30%), Sulphanilamide (24%)
    • Slow rate of absorption (< 0.002): barbituric acid (5%), sulphaguanidine (2%)

Absorption of Drug

60

2/5/2025

61 of 102

Physicochemical factors

  • Limitations of pH partition hypothesis
    • Presence of virtual membrane pH
    • Absorption of ionised drugs
    • Influence of surface area and residence time of drug
    • Presence of aqueous unstirred diffusion layer

Absorption of Drug

61

2/5/2025

62 of 102

Physicochemical factors

  • Limitations of pH partition hypothesis
    • Presence of virtual membrane pH
      • Virtual membrane pH different than luminal pH
      • pH absorption curve

Absorption of Drug

62

2/5/2025

Basic drugs

Acidic drugs

pH of GI Lumen

pH of GI Lumen

63 of 102

Physicochemical factors

  • Limitations of pH partition hypothesis
    • Absorption of ionised drugs
      • pH absorption curve
      • Absorption of ionic drugs
      • Large lipophilic group
    • Influence of surface area and residence time of drug
      • Acidic drugs- stomach
      • Basic drugs- intestine
      • Area available
      • Acidic & basic drugs absorbed well in intestine, long residence

Absorption of Drug

63

2/5/2025

64 of 102

Physicochemical factors

  • Limitations of pH partition hypothesis
    • Presence of aqueous unstirred diffusion layer

Absorption of Drug

64

2/5/2025

Aqueous GIT fluid

Aqueous unstirred diffusion layer

Lipoidal biomembrane

Blood

65 of 102

Physicochemical factors

  • Drug permeability & absorption
    • Absorption is expressed by

      • Where

M = amount of drug absorbed

Peff = effective membrane permeability

A = surface area available for absorption

Capp = apparent luminal drug concentration

tres = residence time of drug in GI lumen

    • Three major properties determine permeability
      • Lipophilicity
      • Polarity of drug
      • Molecular size

Absorption of Drug

65

2/5/2025

66 of 102

Physicochemical factors

  • Drug permeability & absorption
    • Rule of five by Lipinski et al
      • Molecular weight of drug < 500
      • Lipophilicity of drug, log P < 5
      • Number of H bond acceptors < 10
      • Number of H bond donors < 5

Absorption of Drug

66

2/5/2025

67 of 102

Physicochemical factors

  • Drug stability
    • Shelf life of drug during storage
    • Destabilization in GIT
  • Stereochemical nature of drug

Absorption of Drug

67

2/5/2025

68 of 102

Dosage form factors

  • Disintegration time
  • Manufacturing variables
    • Excipients
    • Manufacturing processes
      • Method of granulation
      • Compression force
      • Intensity of packing of capsule content
    • Nature and type of dosage form
    • Product age and storage condition

Absorption of Drug

68

2/5/2025

69 of 102

Dosage form factors

  • Method of granulation
    • Wet granulation
    • Dry granulation
    • APOC method

Absorption of Drug

69

2/5/2025

70 of 102

Dosage form factors

  • Compression force

Absorption of Drug

70

2/5/2025

Rate of drug dissolution

A

B

C

D

Compression force

71 of 102

Dosage form factors

  • Intensity of packing of capsule contents
    • Diffusion of GI fluids into the tightly filled capsules creates a high pressure within the capsule resulting in rapid bursting and dissolution of contents.
    • On other hand, it shows that capsule with finer particles and intense packing have poor drug release and dissolution rate due to decrease in pore size of the compact and poor penetrability by the GI fluids.

Absorption of Drug

71

2/5/2025

72 of 102

Dosage form factors

  • Excipients
    • Vehicle
    • Diluents
    • Binders and granulating agent
    • Disintegrants
    • Lubricants
    • Coating agents
    • Suspending agents/ Viscosity imparters
    • Surfactants
    • Buffers
    • Complexing agents
    • Colorants
    • Crystal growth inhibitors

Absorption of Drug

72

2/5/2025

73 of 102

Dosage form factors

  • Nature and type of dosage form
    • Solutions
    • Emulsions
    • Suspensions
    • Powders
    • Capsules
    • Tablets
    • Coated tablet
    • Enteric coated tablet
    • Sustained release tablet

Absorption of Drug

73

2/5/2025

74 of 102

Patient related factors

    • Gastrointestinal tract
      • Function
      • Length 450 cm
      • Stomach
      • Small intestine
      • Large intestine

Absorption of Drug

74

2/5/2025

75 of 102

Patient related factors

    • Stomach
      • Structure- bag like
      • Small surface area
      • Acidic pH- favors absorption of acidic drugs
      • Acidic pH – favors dissolution of basic drugs
      • Limited gastric residence

Absorption of Drug

75

2/5/2025

76 of 102

Patient related factors

    • Small Intestine
      • Large surface area

Absorption of Drug

76

2/5/2025

77 of 102

Patient related factors

    • Small Intestine
      • Large surface area (200 sqm)
      • Length of small intestine (300-500 cm)
      • Greater blood flow (1 l/min)
      • Favourable pH range (5-7.5)
      • Slow peristaltic movement
      • Prolonged residence time (3-6h)
      • High permeability

Absorption of Drug

77

2/5/2025

78 of 102

Patient related factors

    • Large Intestine
      • Small surface area (0.15 sqm)
      • Length (110 cm)
      • blood flow (0.02 l/min)
      • pH range (6-8)
      • Residence time (6-12 h)
      • Important in absorption of poorly soluble drug and SRDF

Absorption of Drug

78

2/5/2025

79 of 102

Patient related factors

    • Age
      • Infants
        • Gastric pH high
        • Less intestinal surface area
        • Low Blood flow

      • Elderly
        • Altered gastric emptying
        • Decreased intestinal surface area
        • Decreased blood flow
        • Higher incidence of achlorhydria and bacterial overgrowth

Absorption of Drug

79

2/5/2025

80 of 102

Patient related factors

    • Gastric Emptying
      • Passage of drug from stomach to small intestine
      • Rate limiting step for absorption
      • Rapid gastric emptying increases bioavailability
      • Rapid gastric emptying is advisable where
        • Rapid onset of action is desired
        • Dissolution occurs in intestine
        • Drug unstable in stomach
        • Drug best absorbed in intestine
      • Gastric emptying can be promoted by taking drug on empty stomach

Absorption of Drug

80

2/5/2025

81 of 102

Patient related factors

    • Gastric Emptying
      • Delay in gastric emptying is advisable where
        • Food promotes dissolution and absorption
        • Disintegration and dissolution promoted by gastric fluid
        • Drug dissolves slowly
        • Drug irritates gastric mucosa
        • Drug absorbed in proximal part of intestine
      • Gastric emptying rate
      • Gastric emptying time
      • Gastric emptying half life
      • Barium sulphate is used to determine gastric emptying

Absorption of Drug

81

2/5/2025

82 of 102

Patient related factors

    • Gastric Emptying
      • Factors influencing gastric emptying
        • Volume of meal
        • Composition of meal
        • Physical state & viscosity of meal
        • Temperature of meal
        • Gastrointestinal pH
        • Electrolytes & osmotic pressure
        • Body posture
        • Emotional state
        • Exercise
        • Disease state
        • Drugs

Absorption of Drug

82

2/5/2025

83 of 102

Patient related factors

    • Intestinal transit
      • Peristaltic movement- promotes absorption
      • Delayed intestinal transit is desirable
        • SR products
        • Drugs dissolves in intestine
        • Absorption window
        • Slow absorption

Absorption of Drug

83

2/5/2025

84 of 102

Patient related factors

    • Gastrointestinal pH
      • Disintegration- Enteric coated
      • Dissolution
      • Absorption
      • Stability

Absorption of Drug

84

2/5/2025

85 of 102

Patient related factors

    • Disease state
      • Gastrointestinal diseases
        • Achlorhydria
        • Celiac disease
        • Crohn’s disease
        • Malabsorption
        • GI infections
        • Colonic diseases
        • GIT surgery
      • Cardiovascular diseases
      • Hepatic diseases

Absorption of Drug

85

2/5/2025

86 of 102

Patient related factors

    • Blood flow to GIT
      • 28% of cardiac output
      • Sink condition
      • Food alters blood flow

Absorption of Drug

86

2/5/2025

87 of 102

Patient related factors

    • GIT content
      • Food drug interaction

      • Fluid volume
        • Large fluid volume results better dissolution, rapid gastric emptying

Absorption of Drug

87

2/5/2025

Delayed

Decreased

Increased

Unaffected

Aspirin

Penicillins

Griseofulvin

Methyldopa

Paracetamol

Erythromycin

Diazepam

Propylthiouracil

Diclofenac

Tetracyclines

Vitamins

Digoxin

Iron

88 of 102

Patient related factors

    • GIT content
      • Normal GI constituents
        • Mucin decreases absorption of drug
        • Bile salts increases absorption of lipid soluble drugs
      • Drug-drug interactions
        • Physicochemical
          • Adsorption
          • Complexation
          • pH change
        • Physiological
          • Decreased GI transit (Propantheline)
          • Increased gastric emptying (Metoclopramide)
        • Altered GI metabolism (Antibiotics)

Absorption of Drug

88

2/5/2025

89 of 102

Patient related factors

    • First Pass Effect
      • The loss of drug through biotransformation by GIT and Liver during its passage to systemic circulation.
      • Luminal Enzymes
        • Digestive enzymes
          • Enzymes present in gut fluid include intestinal and pancreatic secretions.
          • Hydrolases
            • Hydrolyses esters
            • chloramphenicol palmitate to

chloramphenical

            • Inactivates proteins

Absorption of Drug

89

2/5/2025

90 of 102

Patient related factors

    • First Pass Effect
        • Bacterial enzymes
        • Gut wall enzymes
          • Alcohol dehydrogenase
          • Phase I and Phase II enzymes
        • Hepatic enzymes

Absorption of Drug

90

2/5/2025

91 of 102

Buccal & Sublingual Administration

    • Sublingual Route
      • Under tongue and allowed to dissolve
    • Buccal Route
      • Between cheek & gum
    • Barrier for absorption- oral epithelium
    • Drug absorbed by passive diffusion
    • Advantages
      • Rapid absorption
      • No first pass

Absorption of Drug

91

2/5/2025

92 of 102

Buccal & Sublingual Administration

    • Factors
      • Biphasic solubility of drug is required.
      • pH of saliva (6)
      • Binding of drug to oral mucosa
      • Storage compartment
      • Thickness of oral epithelium
      • Surface area
      • Taste of medicament
    • Antianginals, Antihypertensives, Analgesics, Bronchodilators

Absorption of Drug

92

2/5/2025

93 of 102

Rectal Administration

    • Unconscious patients and children
    • If patient is nauseous or vomiting
    • Easy to terminate exposure
    • Absorption may be variable
    • Good for drugs affecting the bowel such as laxatives
    • Irritating drugs contraindicated
    • Dosage- solutions, suppositories
    • pH (8)
    • Surface area
    • Bypass first pass (lower half)
    • Analgesics, Bronchodilators,

Absorption of Drug

93

2/5/2025

94 of 102

Topical Administration

    • Skin
      • Surface area 2 sqm
      • Blood supply 1/3rd
      • Stratum corneum
      • Mechanisms of absorption
        • Transcellular (passive diffusion)
        • Intercellular (paracellular)
        • Transappendageal
          • Through hair follicles, sweat gland, sebaceous gland

Absorption of Drug

94

2/5/2025

95 of 102

Topical Administration

    • Factors
      • Skin conditions
      • Composition of topical vehicle
      • Application conditions
      • Environmental factors

Absorption of Drug

95

2/5/2025

96 of 102

Topical Administration

    • Skin conditions
      • Thickness of stratus corneum
      • Presence of hair follicles
      • Trauma
      • Hydration of skin
      • Age
      • Skin microflora
      • Skin pH
      • Skin surface lipids
      • Anatomical site

Absorption of Drug

96

2/5/2025

97 of 102

Topical Administration

    • Composition of topical vehicle
      • Vehicle/ base
      • Permeation enhancers
    • Application conditions
      • Rubbing
      • Occulsion
      • Loss of vehicle
    • External factors
      • Environmental humidity and temperature
      • Grooming
      • Exposure to chemicals
      • Chronic use of certain drug

Absorption of Drug

97

2/5/2025

98 of 102

Topical Administration

    • Drug administered
      • Nitroglycerine, lidocaine, testosterone
    • Iontophoresis
      • Delivery of ionic drug into the body -an electric current
    • Sonophoresis
      • Delivery of drug- under influence of ultrasound

Absorption of Drug

98

2/5/2025

99 of 102

Intramuscular Administration

    • Factors
      • Vascularity of the injection site
      • Blood flow to site
      • Lipid solubility and ionisation
      • Molecular size of drug
      • Volume of injection and drug concentration
      • pH, composition and viscosity of injection vehicle

Absorption of Drug

99

2/5/2025

100 of 102

Pulmonary Administration

    • Large surface area of alveoli
    • High perfusion
    • High permeability
    • Bronchodilators, steroids, antiallergics
    • Factors
      • pH
      • Lipid soluble- passive diffusion
      • Ionic, polar- pore transport
      • Particle/ globule size

Absorption of Drug

100

2/5/2025

101 of 102

Intranasal Administration

    • Less surface area
    • High perfusion
    • High permeability
    • Peptides, proteins, Bronchodilators, steroids, antiallergics
    • Factors
      • pH (5.5-6.5)
      • Lipid soluble- passive diffusion
      • Ionic, polar- pore transport
      • Molecular size
      • Mucociliary clearance

Absorption of Drug

101

2/5/2025

102 of 102

Bibliography

  • D. M. Bramhankar and S. B. Jaiswal. Biopharmaceutics and Pharmacokinetics A Treatise. Delhi;Vallabh Prakashan. 2010
  • Jambhekar SS, Breen PJ. Basic Pharmacokinetics. London; Pharmaceutical Press. 2009.
  • Shargel L, Wu-Pong S, Yu ABC. Applied biopharmaceutics and Pharmacokinetics. McGraw Hill. 2007.

Absorption of Drug

102

2/5/2025